CD44 and nasopharyngeal carcinoma: Analogically, in nasopharyngeal carcinoma, tumor cell xenografts of the HK1 cell line with high expressions of CD44 and EpCAM showed a more rapid growth than the ones where tumor cells’ expression of CD44 was diminished [122].